- Home
- TELA
TELA
TELA Bio Inc.
as 02-21-2025 4:00pm EST
TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | MALVERN |
| Market Cap: | 104.0M | IPO Year: | 2019 |
| Target Price: | $9.25 | AVG Volume (30 days): | 183.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.69 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.30 - $7.18 | Next Earning Date: | 03-20-2025 |
| Revenue: | $68,649,000 | Revenue Growth: | 29.34% |
| Revenue Growth (this year): | 30.39% | Revenue Growth (next year): | 25.51% |
Latest TELA Bio Inc. News
TELA Breaking Stock News: Dive into TELA Ticker-Specific Updates for Smart Investing
GlobeNewswire
19 hours ago
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
a month ago
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
a month ago
Retail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28%
GlobeNewswire
2 months ago
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Simply Wall St.
3 months ago
The past five years for TELA Bio (NASDAQ:TELA) investors has not been profitable
GlobeNewswire
3 months ago
TELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare Conference
Simply Wall St.
3 months ago
TELA Bio Third Quarter 2024 Earnings: EPS Beats Expectations
Thomson Reuters StreetEvents
3 months ago
Q3 2024 TELA Bio Inc Earnings Call
Compare TELA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TELA TELA Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.